THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q1 2022
Shares 9,665,000 Value ($000) $9,147 Avg Close — Range —
Q3 2021
Shares 9,665,000 Value ($000) $8,963 Avg Close — Range —
Q3 2020
Shares 2,403,000 Value ($000) $2,115 Avg Close — Range —
Q2 2020
Shares 2,403,000 Value ($000) $2,338 Avg Close — Range —
Q1 2020
Shares 2,403,000 Value ($000) $2,319 Avg Close — Range —
Q4 2019
Shares 10,817,000 Value ($000) $11,230 Avg Close — Range —
Q3 2019
Shares 10,817,000 Value ($000) $9,921 Avg Close — Range —
Q2 2019
Shares 10,817,000 Value ($000) $9,300 Avg Close — Range —
Q1 2019
Shares 10,817,000 Value ($000) $10,504 Avg Close — Range —
Q4 2018
Shares 10,867,000 Value ($000) $11,207 Avg Close — Range —
Q3 2018
Shares 6,289,000 Value ($000) $7,423 Avg Close — Range —
Q2 2018
Shares 1,224,000 Value ($000) $1,216 Avg Close — Range —
Q1 2018
Shares 3,000,000 Value ($000) $3,051 Avg Close — Range —
Q4 2017
Shares 3,475,000 Value ($000) $3,812 Avg Close — Range —
Q3 2017
Shares 8,000,000 Value ($000) $9,835 Avg Close — Range —
Q2 2017
Shares 9,500,000 Value ($000) $12,867 Avg Close — Range —
Q1 2017
Shares 7,000,000 Value ($000) $8,864 Avg Close — Range —
Q4 2016
Shares 6,000,000 Value ($000) $6,851 Avg Close — Range —